When do you start seeing results on Wegovy?

The first month: what 'results' actually looks like early on

Here is something that catches many people off guard. In the first four weeks, the most noticeable change often is not the number on the scales, it is the shift in appetite. The starter dose of 0.25mg is there to let your system adjust, and at that level most people find they feel full sooner, think about food less, and naturally eat smaller amounts. That internal shift is the medicine beginning to work, even if your belt does not feel any different yet.

Some modest weight loss may well happen in this window (a kilogram or two is plausible for many people, and more in some cases) but it is not the headline result that the treatment ultimately delivers. Being impatient with the first four weeks is understandable, especially if you have tried other approaches before. The titration schedule exists for tolerability, not as a delay tactic.

The question of how long Wegovy takes to work is really a question about which phase of treatment you are measuring. Appetite regulation begins early; body composition changes come later and compound over time. Both are part of the result.

Months two to five: the dose-escalation phase and what to expect

Wegovy's licensed titration pathway moves through 0.25mg, 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose, with roughly four weeks at each level. A higher dose approved by the MHRA in early 2026, 7.2mg, represents the current ceiling for semaglutide in weight management and was studied in trials reporting around 20.7% average weight loss over 72 weeks. For most people starting treatment, though, the journey to 2.4mg takes approximately four to five months.

Weight loss typically accelerates as the dose increases. It is common to lose more noticeably at 1.0mg and 1.7mg than at the starting doses, and the pattern of loss is rarely linear, plateaus of a week or two are normal and do not mean the medicine has stopped working. Gastrointestinal side effects such as nausea, constipation or reflux are most likely after dose increases and generally settle within days to a couple of weeks. Understanding that pattern helps you read progress more accurately rather than interpreting a slow week as failure.

The relationship between dose and visible results is one of the most important pieces of context to have at the start. If you are comparing your week-eight results with someone else's month-nine results, the comparison is not meaningful.

Six months and beyond: what the evidence shows

The STEP 1 trial, which underpins Wegovy's weight-management licence, followed adults with obesity over 68 weeks and found an average body-weight reduction of around 15% at the 2.4mg maintenance dose, as published in the New England Journal of Medicine. That is an average: some participants lost considerably more, others less. Individual factors including starting weight, diet, physical activity and any underlying metabolic conditions all influence where a person lands within that range.

NICE's appraisal of semaglutide for weight management, TA875, sets a practical benchmark: if fewer than 5% of body weight has been lost after six months at the highest tolerated dose, continuing treatment should be reviewed. This is not a punishment clause, it is a clinical reality check to ensure the medicine is genuinely helping each individual. Most people who respond well see that 5% threshold passed comfortably before the six-month mark.

If you are tracking when weight loss on Wegovy becomes noticeable, the honest answer is: the scale moves gradually, but the lifestyle and metabolic shifts often run ahead of it. Clothes fitting differently, energy levels changing, and a quieter relationship with food are all part of the picture.

What can slow results down, and when to talk to your prescriber

Several things can blunt the pace of results without indicating that Wegovy is not working. High-calorie liquid intake is one of the most common: the medicine reduces hunger but does not suppress the appetite-signalling from drinks in the same way. Sleep deprivation and high stress can work against the weight-loss effect through cortisol and hunger hormones. And for people on tirzepatide as an alternative, the comparison between Wegovy and Mounjaro is worth exploring with a prescriber, since the SURMOUNT-5 trial found tirzepatide produced greater average weight reduction over 72 weeks.

If you have reached your maintenance dose, maintained it for three months, kept to lifestyle changes and still see minimal movement, that conversation with your prescriber is overdue, not premature. A prescriber can review whether the dose, the medicine, or the broader plan needs adjusting, and reading about when you should start seeing results from Wegovy can help you frame those conversations with realistic expectations. You can also explore when most people start to see results from Wegovy to get a clearer sense of whether your own progress is tracking within a normal range. At nume, a named clinician reviews every repeat order before it is approved, so there are natural checkpoints built into the process. You can check your eligibility and start a free consultation to understand whether Wegovy is the right starting point for you.